ClinicalTrials.Veeva

Menu

Longitudinal Cognitive Assessment by BoCA

A

Alzheimer's Light

Status

Enrolling

Conditions

Alzheimer Disease
Frontotemporal Dementia
Multiple Sclerosis
Mild Cognitive Impairment
Parkinson Disease
Vascular Dementia
TBI

Treatments

Diagnostic Test: Boston Cognitive Assessment (BoCA)

Study type

Observational

Funder types

Industry

Identifiers

NCT04114994
BoCA001

Details and patient eligibility

About

The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.

Full description

The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not- repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.

BoCA includes eight subtests in the following domains: Memory/Immediate Recall, Memory/Delayed Recall, Executive function/ Visuospatial, Executive function/ Mental rotation, Attention, Mental math, Language/Prefrontal Synthesis, and Orientation. The maximum total score is 30. Higher score indicates better cognitive performance.

After BoCA is completed, the domain scores and total score are provided immediately. Users will also receive an email with the link to the full report with progress charts.

The BoCA evaluation can help doctors figure out if an underlying condition is causing a patient's cognitive decline. Many treatable conditions such as sleep disorders, mood problems, heavy metal accumulation, as well as lack of movement and social interactions can affect memory and thinking.

Our goal is to reduce barriers for patients to receive the testing that may benefit their treatment and health through the use of digital technology.

Enrollment

10,000 estimated patients

Sex

All

Ages

50+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

age 50 or older

Exclusion criteria

younger than 50 years

Trial design

10,000 participants in 8 patient groups

Alzheimer's Disease
Treatment:
Diagnostic Test: Boston Cognitive Assessment (BoCA)
Mild Cognitive Impairment
Treatment:
Diagnostic Test: Boston Cognitive Assessment (BoCA)
Frontotemporal Dementia
Treatment:
Diagnostic Test: Boston Cognitive Assessment (BoCA)
Vascular Dementia
Treatment:
Diagnostic Test: Boston Cognitive Assessment (BoCA)
Parkinson Disease
Treatment:
Diagnostic Test: Boston Cognitive Assessment (BoCA)
Traumatic Brain Injury (TBI)
Treatment:
Diagnostic Test: Boston Cognitive Assessment (BoCA)
Multiple Sclerosis
Treatment:
Diagnostic Test: Boston Cognitive Assessment (BoCA)
No diagnosis
Treatment:
Diagnostic Test: Boston Cognitive Assessment (BoCA)

Trial contacts and locations

1

Loading...

Central trial contact

ANDREY VYSHEDSKIY, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems